SCHEMBL14709398

SCHEMBL14709398

COc1ccc(C2=Nc3cccc4cccc(c34)N2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 11/20 1.00
▸ KMT2A Q03164 10/20 1.00
▸ MEN1 O00255 9/20 1.00
▸ ALDH1A1 P00352 4/20 1.00
▸ CYP1A2 P05177 2/20 1.00
▸ CYP2D6 P10635 2/20 1.00
▸ LMNA P02545 4/20 0.76
▸ NPC1 O15118 2/20 0.76
▸ MAPT P10636 12/20 0.68
▸ KDM4E B2RXH2 3/20 0.68
▸ MCL1 Q07820 3/20 0.68
▸ USP2 O75604 2/20 0.68
▸ ALOX12 P18054 1/20 0.68
▸ RAB9A P51151 1/20 0.68
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ ESR1 P03372 1/20 0.49
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10085969 0.88 KMT2A (0.87) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL10086015 0.86 KMT2A (0.84) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL4159123 0.84 KMT2A (0.74) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL11288124 0.82 GAA (0.70) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL11276978 0.82 GAA (0.70) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL3395971 0.82 KMT2A (1.00) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL11279534 0.81 KMT2A (0.74) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL11874703 0.81 KMT2A (0.74) GAAKMT2AMEN1ALDH1A1CYP1A2
SCHEMBL10084915 0.81 GAA (0.74) GAAKMT2AMEN1ALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL11862709 0.80 KMT2A (0.97) GAAKMT2AMEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013023300-A1 INHIBITORS OF ANDROGEN RECEPTOR ACTIVATION FUNCTION-2 (AF2) AS THERAPEUTICS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — WO disclosed
Send feedback